News

What Shape and Size of Tablets Do Our Patients Prefer?

14. 3. 2022 Source: Cardiovascular Continuum

The size and shape of tablets can affect patients' compliance with treatment. The following article provides an overview of conclusions from two foreign studies focused on influencing the difficulty of swallowing and handling tablets depending on their shape and size.

How many heart failure patients do not take adequate doses of beta-blockers even though they could?

A British study published last year investigated the proportion of heart failure patients with reduced ejection fraction (HFrEF) who do not take an adequate dose of beta-blockers (BB), despite having…

14. 3. 2022 Source: Cardiovascular Continuum

Dust mite allergy is a significant risk factor (not only) for the development of asthma

Dust mite allergy is the most common cause of year-round allergic rhinitis in our country. Its prevalence is increasing every year, but non-specific manifestations also cause its underdiagnosis.…

14. 3. 2022 Source: Dust Mite Allergy

Efficacy of Sublingual Immunotherapy in Patients with Atopic Dermatitis Sensitized to Dust Mite Allergens

In patients with atopic dermatitis (AD), sensitization to house dust mite allergens is common. According to studies, subcutaneous immunotherapy (SCIT) represents an effective adjunct therapy. The…

11. 3. 2022 Source: Dust Mite Allergy

Weight-Based Enoxaparin Dosing vs. Standard Dosing in Trauma Patients

Thromboembolic disease is a common comorbidity in adult trauma patients, thus making routine thromboprophylaxis appropriate for these patients, most often in the form of low-molecular-weight heparins…

9. 3. 2022 Source: Thromboprophylaxis

EMA Approved Empagliflozin for the Treatment of Heart Failure Regardless of Left Ventricular Ejection Fraction

Prague, March 8, 2022 –⁠ Hundreds of thousands of patients in the Czech Republic can soon look forward to a treatment that may positively influence the progression of their disease. The European…

8. 3. 2022 Source: Heart Failure

Fexofenadine –⁠ Non-Sedative and Immunomodulatory Antihistamine in the Treatment of Allergic Symptoms

One of the biggest limitations of traditional antihistamines is the sedative effect on the central nervous system. Newer antihistamines do not cause sedation, are not associated with serious side…

3. 3. 2022 Source: Viral infections

Does gliflozin treatment for heart failure have greater benefits in diabetics?

Inhibitors of glucose reabsorption in the proximal tubule are represented on the domestic market by several molecules including empagliflozin. The EMPEROR-Reduced study monitored the impact of…

3. 3. 2022 Source: Heart Failure

Adequate Anti-Xa Levels Are More Often Achieved in Trauma Patients When Dosing Enoxaparin Based on Weight

Thromboembolic disease (TED) is a well-known preventable cause of morbidity and mortality in trauma patients. To improve their prognosis, pharmacological thromboprophylaxis, such as with low…

3. 3. 2022 Source: Thromboprophylaxis

Is Dupilumab Effective in AD Therapy for Patients for Whom Cyclosporine A Fails or Cannot Be Given?

Severe forms of atopic dermatitis (AD) may require systemic therapy. However, the immunosuppressant cyclosporine A does not have sufficient efficacy in some patients with AD or is contraindicated for…

3. 3. 2022 Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation

Use of Specific Inhibition of Anticoagulant Therapy During Heart Transplantation

A recent report from real clinical practice summarizes the experiences of physicians with dabigatran therapy and the reversal of its anticoagulant effect using idarucizumab in 10 patients before…

1. 3. 2022 Source: Anticoagulant Treatment

Micronized Diosmin Obtained Reimbursement, Based on Its Therapeutic Interchangeability with MPFF

On January 11, 2022, the State Institute for Drug Control (SÚKL) issued a decision on the determination of the amount and conditions of reimbursement from health insurance for a drug containing…

28. 2. 2022 Source: Venous Insufficiency

Metamizole, even after 100 years on the market, remains an important component of postoperative pain therapy

Metamizole has been used in the therapy of a wide range of acute and chronic pains for 100 years. Thanks to a number of advantages, it still represents one of the most frequently used analgesics in…

28. 2. 2022 Source: Analgesia

Administration of Erdosteine after Severe COVID-19 in the Early Period after Discharging Patients from the Healthcare Facility

Erdosteine is a mucomodulatory drug used in the treatment of various acute and chronic respiratory diseases. According to available evidence, its mechanism of action is complex, encompassing not only…

28. 2. 2022 Source: Cough Therapy

nemocniční postel rozhovor lékaře s pacientem

Even in Severe Cases of HAE, Individualized Treatment is Crucial –⁠ Case Study

As part of the case seminar from the HAExpert series, held on December 1, 2021, which specifically focused on the treatment of hereditary angioedema (HAE) in specific patients, Dr. Roman Hakl from…

25. 2. 2022 Source: Hereditary Angioedema

1 … 58 59 60 61 62 … 114

Back Filter by speciality

Remove filters